Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01680835 · ClinicalTrials.gov registry record · NA
EverFlex Post Approval Study
A NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 20
- Study locations
NCT01680835 is a NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease that has completed, run by Medtronic Endovascular. The registered enrollment target is 108 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The trial reports 20 study locations across 15 states.
The verdict
NCT01680835, a NA study of Peripheral Arterial Disease and Lower Extremity Arterial Disease, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 20
- Study locations
Study Summary
This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal arteries.
Conditions Studied
Interventions
- DEVICE EverFlex™ Self-Expanding Peripheral Stent System
Study Locations (20)
Pennsylvania
- Lankenau Institute for Medical Research - Bryn Mawr
- Thomas Jefferson University - Philadelphia
- Allegheny General Hospital - Pittsburgh
California
- Memorial Medical Center - Modesto
- Sutter Memorial Hospital - Sacramento
Illinois
- DuPage Medical Group - Downers Grove
- Rockford Cardiovascular Associates - Rockford
South Dakota
- Black Hills Cardiovascular Research - Rapid City
- Sanford Research - Sioux Falls
Arizona
- St. Luke's Medical Center - Phoenix
Delaware
- Christiana Care Health Services - Newark
Florida
- First Coast Cardiovascular Institute, P.A. - Jacksonville
Georgia
- Augusta Vascular Center - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2013-01-14 |
| Est. Completion | 2019-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01680835
The ClinicalTrials.gov registry entry for NCT01680835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which EverFlex™ Self-Expanding Peripheral Stent System is the first listed.
NCT01680835 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Pennsylvania, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT01680835 about?
NCT01680835 is a clinical study titled "EverFlex Post Approval Study". This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal arteries.
What is the current status of trial NCT01680835?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2013-01-14. Estimated completion is 2019-02-04.
What conditions does trial NCT01680835 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease, Lower Extremity Arterial Disease.
What interventions are being tested in trial NCT01680835?
The interventions under investigation include: EverFlex™ Self-Expanding Peripheral Stent System (DEVICE).
Who is sponsoring clinical trial NCT01680835?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01680835 being conducted?
This trial has 20 study locations across Arizona, California, Delaware, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.